Danaher Co. (NYSE:DHR) Shares Acquired by Pittenger & Anderson Inc.

Pittenger & Anderson Inc. lifted its position in shares of Danaher Co. (NYSE:DHR) by 0.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 68,298 shares of the conglomerate’s stock after purchasing an additional 475 shares during the quarter. Pittenger & Anderson Inc.’s holdings in Danaher were worth $15,678,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the 4th quarter worth approximately $27,000. Decker Retirement Planning Inc. purchased a new position in shares of Danaher during the 4th quarter valued at approximately $31,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher during the 4th quarter valued at approximately $31,000. Strategic Financial Concepts LLC purchased a new position in shares of Danaher during the 4th quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC lifted its position in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after buying an additional 57 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. KeyCorp increased their target price on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Royal Bank of Canada reiterated an “outperform” rating and set a $277.00 target price (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Guggenheim started coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price objective on the stock. Scotiabank started coverage on Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective on the stock. Finally, JPMorgan Chase & Co. decreased their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Danaher Stock Up 1.5 %

Shares of NYSE:DHR opened at $206.66 on Monday. The business has a 50-day moving average price of $229.53 and a 200 day moving average price of $249.13. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $149.26 billion, a price-to-earnings ratio of 39.14, a PEG ratio of 2.68 and a beta of 0.83. Danaher Co. has a 12-month low of $196.80 and a 12-month high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the business posted $2.09 earnings per share. Sell-side analysts expect that Danaher Co. will post 7.67 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.52%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio is currently 20.45%.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.